Your browser doesn't support javascript.
loading
Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley, Catherine; Torr, Bethany; Sud, Amit; Rowlands, Charlie F; Way, Rosalind; Snape, Katie; Hanson, Helen; Swanton, Charles; Broggio, John; Lucassen, Anneke; McCartney, Margaret; Houlston, Richard S; Hingorani, Aroon D; Jones, Michael E; Turnbull, Clare.
Afiliação
  • Huntley C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; National Cancer Registration and Analysis Service, National Health Service (NHS) England, London, UK.
  • Torr B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Sud A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Haemato-oncology Unit, The Royal Marsden Hospital NHS Foundation Trust, Sutton, UK.
  • Rowlands CF; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Way R; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Snape K; St Georges University of London, London, UK; South West Thames Regional Genetics Service, St George's Hospital, London, UK.
  • Hanson H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; South West Thames Regional Genetics Service, St George's Hospital, London, UK.
  • Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK.
  • Broggio J; National Cancer Registration and Analysis Service, National Health Service (NHS) England, London, UK.
  • Lucassen A; Wellcome Centre for Human Genetics and Centre for Personalised Medicine, University of Oxford, Oxford, UK.
  • McCartney M; Population and Behavioural Science Division, School of Medicine, University of St Andrews, St Andrews, UK.
  • Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Hingorani AD; University College London British Heart Foundation Research Accelerator Centre, London, UK; Health Data Research UK, London, UK; National Institute of Health Research Biomedical Research Centre and Institute of Cardiovascular Science, Faculty of Population Health, University College London, London,
  • Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; National Cancer Registration and Analysis Service, National Health Service (NHS) England, London, UK; Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: clare.turnbull@icr.
Lancet Oncol ; 24(6): 658-668, 2023 06.
Article em En | MEDLINE | ID: mdl-37178708
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Testiculares / Neoplasias da Mama / Neoplasias Colorretais Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Testiculares / Neoplasias da Mama / Neoplasias Colorretais Idioma: En Ano de publicação: 2023 Tipo de documento: Article